| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allografts for Follicular Non-Hodgkin Lymphoma: Why Never Is No Longer an Acceptable Answer
|
Stiff, Patrick J.
|
|
2016
|
22 |
8 |
p. 1346-1347
2 p.
|
artikel
|
| 2 |
Analysis of Cyclosporine A Levels Supports New Dosing Guidelines in Adult Double-Unit Cord Blood Transplant Recipients to Optimize Immunosuppression Early Post-Transplant
|
Bhatt, Valkal
|
|
2016
|
22 |
8 |
p. 1533-1534
2 p.
|
artikel
|
| 3 |
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
|
Laribi, Kamel
|
|
2016
|
22 |
8 |
p. 1357-1367
11 p.
|
artikel
|
| 4 |
Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
|
Rodriguez, Tulio E.
|
|
2016
|
22 |
8 |
p. 1391-1396
6 p.
|
artikel
|
| 5 |
Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease
|
Pirsl, Filip
|
|
2016
|
22 |
8 |
p. 1517-1524
8 p.
|
artikel
|
| 6 |
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis
|
Ustun, Celalettin
|
|
2016
|
22 |
8 |
p. 1348-1356
9 p.
|
artikel
|
| 7 |
Cytomegalovirus Infection after CD34+-Selected Hematopoietic Cell Transplantation
|
Huang, Yao-Ting
|
|
2016
|
22 |
8 |
p. 1480-1486
7 p.
|
artikel
|
| 8 |
Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation
|
Cornetto, Marie Alice
|
|
2016
|
22 |
8 |
p. 1511-1516
6 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2016
|
22 |
8 |
p. A2-
1 p.
|
artikel
|
| 10 |
Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell Lymphoma
|
Lisenko, Katharina
|
|
2016
|
22 |
8 |
p. 1397-1402
6 p.
|
artikel
|
| 11 |
Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation
|
Barnum, Jessie L.
|
|
2016
|
22 |
8 |
p. 1487-1492
6 p.
|
artikel
|
| 12 |
Erratum to: “What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia” [Biol Blood Marrow Transplant 2016;22:731-743]
|
Dyer, Gemma
|
|
2016
|
22 |
8 |
p. 1537-
1 p.
|
artikel
|
| 13 |
Expecting a Miracle Harvest after Miracle Growth: Controversies of Granulocyte Colony-Stimulating Factor–Mobilized Matched Sibling Donor Transplantation
|
Lazaryan, Aleksandr
|
|
2016
|
22 |
8 |
p. 1343-1345
3 p.
|
artikel
|
| 14 |
Factors Predicting Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center
|
Solh, Melhem
|
|
2016
|
22 |
8 |
p. 1403-1409
7 p.
|
artikel
|
| 15 |
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study
|
Couban, Stephen
|
|
2016
|
22 |
8 |
p. 1410-1415
6 p.
|
artikel
|
| 16 |
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation
|
Abel, Gregory A.
|
|
2016
|
22 |
8 |
p. 1504-1510
7 p.
|
artikel
|
| 17 |
Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing
|
Damlaj, Moussab
|
|
2016
|
22 |
8 |
p. 1431-1439
9 p.
|
artikel
|
| 18 |
Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence
|
Rizk, Mina
|
|
2016
|
22 |
8 |
p. 1416-1423
8 p.
|
artikel
|
| 19 |
Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Adults
|
Le Bourgeois, Amandine
|
|
2016
|
22 |
8 |
p. 1473-1479
7 p.
|
artikel
|
| 20 |
Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation
|
Li, Zhuoyan
|
|
2016
|
22 |
8 |
p. 1368-1375
8 p.
|
artikel
|
| 21 |
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies
|
Kang, Hyoung Jin
|
|
2016
|
22 |
8 |
p. 1455-1459
5 p.
|
artikel
|
| 22 |
Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
|
Wang, Yu-Tong
|
|
2016
|
22 |
8 |
p. 1376-1382
7 p.
|
artikel
|
| 23 |
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies
|
Pasquini, Marcelo C.
|
|
2016
|
22 |
8 |
p. 1424-1430
7 p.
|
artikel
|
| 24 |
Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders
|
Madden, Lisa M.
|
|
2016
|
22 |
8 |
p. 1467-1472
6 p.
|
artikel
|
| 25 |
Masthead (Purpose and Scope)
|
|
|
2016
|
22 |
8 |
p. A1-
1 p.
|
artikel
|
| 26 |
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
|
DeFilipp, Zachariah
|
|
2016
|
22 |
8 |
p. 1493-1503
11 p.
|
artikel
|
| 27 |
Officers and Directors of ASBMT
|
|
|
2016
|
22 |
8 |
p. A4-
1 p.
|
artikel
|
| 28 |
Proteome Profiling in Lung Injury after Hematopoietic Stem Cell Transplantation
|
Bhargava, Maneesh
|
|
2016
|
22 |
8 |
p. 1383-1390
8 p.
|
artikel
|
| 29 |
Quality of Life: A Tiebreaker in CEBPA Double-Mutated Acute Myeloid Leukemia
|
Rashidi, Armin
|
|
2016
|
22 |
8 |
p. 1535-1536
2 p.
|
artikel
|
| 30 |
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network
|
Laport, Ginna G.
|
|
2016
|
22 |
8 |
p. 1440-1448
9 p.
|
artikel
|
| 31 |
Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa
|
Spitzer, Barbara
|
|
2016
|
22 |
8 |
p. 1449-1454
6 p.
|
artikel
|
| 32 |
Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing Outcomes
|
Al Mulla, Naima
|
|
2016
|
22 |
8 |
p. 1525-1530
6 p.
|
artikel
|
| 33 |
Table of Contents
|
|
|
2016
|
22 |
8 |
p. A5-A6, A10-A11, A16
|
artikel
|
| 34 |
The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children
|
Saber, Wael
|
|
2016
|
22 |
8 |
p. 1460-1466
7 p.
|
artikel
|
| 35 |
Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation
|
Arora, Mukta
|
|
2016
|
22 |
8 |
p. 1531-1532
2 p.
|
artikel
|
Tijdschrift beschrijving